Category: Series
-
Weed roll-up BZAM (BZAM.C) used stock to buy assets <60 days before asking for creditor protection
You’ve built a decent little company. You’ve grown some brands. You’re feeling okay about things when a bigger company comes along, offers you a bunch of their stock, making you a significant shareholder, and tells you there are other strong hands in the investor base, including the wealthy chairman who has been lending the company…
-
Lancaster Resources (LCR.C) adds a second run at green energy with uranium play
Traditionally, mid-to-large sized public companies stick to their knittting. A biotech company stays in biotech, a weed company stays in weed, a gold company shies away from oil and gas. But the beauty of being a microcap is you can be quick on your feet. Sure, you’ve got yourself a lithium project that checks all…
-
Bitcoin on the path to new all time record highs
Bitcoin has topped $57,000 for the first time since 2021. And from a technical perspective, the world’s largest cryptocurrency is on the path to printing new all time record highs. In terms of fundamentals? The Bitcoin ETF. This was the catalyst many bitcoin bulls were waiting for. An ETF makes bitcoin ‘legit’ in the eyes…
-
Replenish Nutrients (ERTH.C) is to synthetic fertilizers as Tesla was to Ford
Imagine if the gas you put in your car caused your engine to degrade and polluted the streets and rising prices raised the cost of every product, and the oil companies and car companies just shrugged and said ‘that’s how it is, man, oh well.’ You might be saying, “Yeah, they actually do that stuff…
-
Rising Sun, Rising Stocks: Japanese Nikkei takes out 1989 highs
This might be one of those “see we told you so” articles. While most investors are talking about Nvidia earnings and how it is holding up the US stock markets (S&P 500 and the Dow Jones have printed new all time record highs today with the Nasdaq not too far away), I think market news…
-
Oil about to trigger an inflation uptick surprise?
With the January 2024 inflation data coming out higher and hotter than expected in the US, investors are re-evaluating the battle against inflation. Is it over? Is it too early to declare victory? The Fed has said that the battle is not quite over but progress is going well. But just not well enough for…
-
Top 5 stock gainers and losers: THNK.V, FLY.V, PUL.V
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is a summary of the intraday action of assets: Top 5 Stocks Think Research Corporation (THNK.V) Market Cap ~ $24 million Think Research Corporation provides knowledge-based digital…
-
Behind the scenes on the public markets: Why everything is broken and how to fix it
In my opinion, journalism – actual journalism – isn’t just about reporting what you see that’s wrong in the world, but working to get the things that are wrong.. righted. Telling people a building collapsed is easy. Reporting on the press conference that follows is ‘phone it in’ stuff. But talking about it every day…
-
How to start a good rare earths company: Neoterrex Minerals (NTX.V) lays it out
Years ago, after the graphite spike and before the lithium boom, the cobalt jump, and the vanadium moment, rare earths had a hot second in the sun. It wasn’t a long second, but the internet was booming and electric vehicles were being thought about and we all had rechargeable batteries jammed into anything with a…
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…
